Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
J-CRITICAL trial of favipiravir plus methylprednisolone for COVID-19 with mild respiratory failure
jRCTs041200025Phase 2Completed
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of favipiravir and methylprednisolone in coronavirus disease 2019 (COVID-19). Started Jul 2020; status: completed.
02
Drugs
favipiravirmethylprednisolone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCTs041200025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041200025.